Abstract:We designed active anticancer agents (3 a–j) based on coumarin‐quinazolinone. In testing on A‐549 and MDA‐MB‐231 cell lines, 3 i excelled against A‐549 (IC50 7.11 μM), and 3 g outperformed doxorubicin in MDA‐MB‐231 (IC50 5.12 μM). HEK293 cytotoxicity confirmed safety. Molecular docking showed favorable interactions with Topo IIα ATPase/AMP‐PNP. SwissADME assessed ADME properties. Cancer remains a complex global threat causing widespread deaths. Developing effective anticancer agents despite advancements still remained challenging. In this work it is designed and synthesised therapeutically active anticancer agents based on coumarin‐quinazolinone 5(a–j) through nucleophilic substitution reaction of 4‐bromomethyl coumarin derivatives with 6,7‐bis(2‐methoxyethoxy)quinazolin‐4(3H)‐one and characterised by using FTIR, 1HNMR, 13C NMR and LCMS analysis. The compounds 5(a–j) were screened for in vitro anticancer activity against A‐549 lung cancer cell lines and MDA‐MB‐231 cell lines. Compound 5i emerged as the most promising antiproliferative candidate demonstrating an IC50 value of 7.11 μM against A‐549 cell lines. Meanwhile compound 5g found as a hit candidate in the case of MDA‐MB‐231, exhibiting an IC50 of 5.12 μM, surpassing the potency of the standard drug doxorubicin (IC50 5.89 μM). Further, the safety profile of coumarin‐quinazolinone scafolds (5a–j) were examined for their cytotoxicity towards human embryonic kidney cell lines (HEK293). It was found that the most active compounds exhibited good safety profile towards human embryonic cell lines. Additionally, molecular docking investigations confirmed that compounds 5(a–j) exhibited elevated docking scores and demonstrated favourable interactions with the HER2 (PDB:3PP0) and VEGFR2 (PDB:4ASE). Furthermore, we investigated the ADME properties using the SwissADME tool.

Coumarin Sulfonamides and Amides Derivatives: Design, Synthesis, and Antitumor Activity In Vitro

Synthesis and Biological Evaluation of a Novel Class of Coumarin Derivatives.

Design, Synthesis, Mechanisms of Action, and Toxicity of Novel 20(S)-Sulfonylamidine Derivatives of Camptothecin As Potent Antitumor Agents

Design, Synthesis and Biological Evaluation of Novel 3-Substituted 4-Anilino-coumarin Derivatives As Antitumor Agents

Design, Synthesis, and in Vitro Evaluation of Novel 3, 7‐disubstituted Coumarin Derivatives As Potent Anticancer Agents

Excellent antitumor and antimetastatic activities based on novel coumarin/pyrazole oxime hybrids

Design and Synthesis of Potent Anticancer Agents Using Coumarin‐Quinazolinone Based Scaffolds: Exploration of ADME Properties and Molecular Docking Studies

Synthesis and Biological Evaluation of 4-(1,2,3-triazol-1-yl)coumarin Derivatives As Potential Antitumor Agents

Synthesis and Anticancer Evaluation of Novel Coumarin Derivatives

Coumarin sulfonamides derivatives as potent and selective COX-2 inhibitors with efficacy in suppressing cancer proliferation and metastasis

Design, Synthesis, and Evaluation of in Vitro and in Vivo Anticancer Activity of 4-Substituted Coumarins: A Novel Class of Potent Tubulin Polymerization Inhibitors.

Design, Synthesis, Biological Activity and Molecular Docking Study of Coumarin Derivatives Bearing 2-Methylbiphenyl Moiety

Design, semi-synthesis and bioevaluation of koumine-like derivatives as potential antitumor agents in vitro and in vivo

Design, synthesis and cytotoxic evaluation of novel betulonic acid-diazine derivatives as potential antitumor agents

Synthesis and Antitumor Evaluation of a Novel Series of Triaminotriazine Derivatives.

Synthesis and biological evaluation of sulfur-containing shikonin oxime derivatives as potential antineoplastic agents

Synthesis and Bioactivities of Penta-1,4-dien-3-one Derivatives Containing a Coumarin Moiety

Design, Synthesis, and Evaluation of New 2-Oxoquinoline Arylaminothiazole Derivatives As Potential Anticancer Agents.

Novel Hybrids of 3-Substituted Coumarin and Phenylsulfonylfuroxan as Potent Antitumor Agents with Collateral Sensitivity against MCF-7/ADR.

Design, Synthesis, and Antitumor Evaluation of Novel Naphthalimide Derivatives

Design, Synthesis, Structure-Activity Relationships and Mechanism of Action of New Quinoline Derivatives As Potential Antitumor Agents